tirzepatide surmount 1 for the treatment of obesity: Rationale and design of the clinical development program - Roux - 2023 - Obesity SURMOUNT-1 demonstrates substantial weight loss
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9























